Iomeron

Iomeprol, the active ingredient in Iomeron, is a non‑ionic iodinated contrast media presented as a solution for injection for intra‑arterial, intra‑articular and intrathecal use. It enhances radiographic visualization during diagnostic imaging procedures such as angiography, arthrography and myelography.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and imaging centres worldwide, ensuring quality, regulatory compliance, reliable logistics and dedicated technical support.

Iomeron (iomeprol) is used as a radiographic contrast agent to improve X‑ray based imaging. Angiography: provides clear delineation of blood vessels for accurate diagnosis. Arthrography: enhances joint space visualization to assess cartilage and ligaments. Myelography: improves contrast of the spinal canal for detailed evaluation of neural structures. Other diagnostic imaging procedures requiring intra‑arterial, intra‑articular or intrathecal contrast: facilitates detailed anatomical assessment in specialized studies.

Adverse reactions to Iomeron can range from mild and transient to severe, though serious events are uncommon. Common Side Effects: - Warmth or flushing sensation during injection - Metallic taste in the mouth - Nausea or mild vomiting Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with respiratory distress - Contrast‑induced nephropathy leading to acute kidney injury - Significant hypotension or cardiovascular collapse

Before using Iomeron, several safety considerations should be observed. Renal function assessment: evaluate serum creatinine and eGFR to identify risk of nephrotoxicity. Allergy screening: confirm no known iodine or contrast media hypersensitivity. Use lowest effective volume: limit exposure to the minimum required for diagnostic quality. Vital sign monitoring: observe blood pressure and heart rate during and after injection. Contraindication in severe hyperthyroidism: avoid use in uncontrolled thyroid disease. Store at ambient temperature: keep in original container, protect from light and moisture.

Iomeron may interact with other medicines, influencing safety or efficacy. Major Interactions (Avoid): - Concurrent nephrotoxic agents (e.g., aminoglycosides, high‑dose NSAIDs): increase risk of renal injury. - Metformin in patients with reduced renal function: risk of lactic acidosis. - Radioactive iodine therapy (I‑131): iodine load may interfere with treatment. Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask contrast‑induced tachycardia. - Diuretics: affect fluid balance and renal clearance. - ACE inhibitors or ARBs: may potentiate renal effects, monitor kidney function.